Vitamin B3 may help prevent some common skin cancers
the ONA take:
A large study has found that a certain B3 vitamin may reduce the risk of the most common skin cancers. Melanoma was not involved in the study, only the more common basal and squamous cell cancers.
The study, funded by Australia’s National Health and Medical Research Council, included 386 people who had at least two skin cancers in the previous 5 years.
In the double-blind study, the participants took either 500 mg of the B3 vitamin nicotinamide or dummy pills twice a day for 1 year, and were followed for 6 months after they stopped taking the pills. Those taking the vitamin had a 23% lower rate of new cancers.
In addition, the rate of precancers was also reduced, by 11% after 3 months and 20% after 9 months. However, the benefits did not continue once the pills were stopped. Six months after discontinuing the pills, the rate of new skin cancers was similar in both groups.
Nicotinamide is thought to help repair the DNA damage caused by sun exposure. Vitamin use for cancer prevention, however, is controversial, and some studies have even found them to be harmful.
Furthermore, despite the positive results of this study, the researchers stress that vitamin use is not for people who have not yet had one of these cancers and that people should always practice basic sun-sensible behaviors.
A certain B3 vitamin may reduce the risk of the most common skin cancers.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Exercise May Mitigate Doxorubicin-related Cardiotoxicity
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
- Exercise May Mitigate Cardiotoxicity Associated With Doxorubicin Treatment
- Mobile Health Apps Becoming More Popular Among Patients and Clinicians
- Online Learning Modules Improve Exercise Counseling, But Not Participation
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|